In CRC, the carcinoembryonic antigen (CEA) is the most frequently analyzed marker, and we have previously developed a reliable and reproducible molecular method for carcino-embryonic antigen-like cellular adhesion molecule 5 (CEACAM5) mRNA-positive CTC detection in CRC patients [11,13]. Here, CEACAM5 is linked to colorectal carcinoma.